Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Jan;22(1):63-70.
doi: 10.7861/clinmed.2020-1107.

Utility of severity assessment tools in COVID-19 pneumonia: a multicentre observational study

Affiliations
Observational Study

Utility of severity assessment tools in COVID-19 pneumonia: a multicentre observational study

Asim Ahmed et al. Clin Med (Lond). 2022 Jan.

Abstract

Background: Severity scores in pneumonia and sepsis are being applied to SARS-CoV-2 infection. We aimed to assess whether these severity scores are accurate predictors of early adverse outcomes in COVID-19.

Methods: We conducted a multicentre observational study of hospitalised SARS-CoV-2 infection. We assessed risk scores (CURB65, qSOFA, Lac-CURB65, MuLBSTA and NEWS2) in relation to admission to intensive care or death within 7 days of admission, defined as early severe adverse events (ESAE). The 4C Mortality Score was also assessed in a sub-cohort of patients.

Findings: In 2,387 participants, the overall mortality was 18%. In all scores examined, increasing score was associated with increased risk of ESAE. Area under the curve (AUC) to predict ESAE for CURB65, qSOFA, Lac-CURB65, MuLBSTA and NEWS2 were 0.61, 0.62, 0.59, 0.59 and 0.68, respectively. AUC to predict ESAE was 0.60 with ISARIC 4C Mortality Score.

Conclusion: None of the scores examined accurately predicted ESAE in SARS-CoV-2 infection. Non-validated scores should not be used to inform clinical decision making in COVID-19.

Keywords: COVID-19; collaborative; pneumonia; severity score.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Modified consort diagram demonstrating inclusion of cases. For a detailed overview of missing data, see supplementary material S1, Table S1. CURB65 = confusion, urea nitrogen, respiratory rate, blood pressure and age of 65 years or older score; Lac-CURB65 = lactate, confusion, urea nitrogen, respiratory rate, blood pressure and age of 65 years or older score; MuLBSTA = multilobular infiltration, hypo-lymphocytosis, bacterial coinfection, smoking history, hyper-tension and age score; NEWS2 = National Early Warning Score 2; qSOFA = quick Sequential (Sepsis-related) Organ Failure Assessment; RT-PCR = reverse transcription – polymerase chain reaction.
Fig 2.
Fig 2.
Receiver operator curve for early severe adverse event in all SARS-CoV-2 infection. CURB65 = confusion, urea nitrogen, respiratory rate, blood pressure and age of 65 years or older score; Lac-CURB65 = lactate, confusion, urea nitrogen, respiratory rate, blood pressure and age of 65 years or older score; MuLBSTA = multilobular infiltration, hypo-lymphocytosis, bacterial coinfection, smoking history, hyper-tension and age score; NEWS2 = National Early Warning Score 2; qSOFA = quick Sequential (Sepsis-related) Organ Failure Assessment; ROC = area under the receiver operator curve.
Fig 3.
Fig 3.
Receiver operator curve for early severe adverse event in COVID-19-associated community-acquired pneumonia only. CURB65 = confusion, urea nitrogen, respiratory rate, blood pressure and age of 65 years or older score; Lac-CURB65 = lactate, confusion, urea nitrogen, respiratory rate, blood pressure and age of 65 years or older score; MuLBSTA = multilobular infiltration, hypo-lymphocytosis, bacterial coinfection, smoking history, hyper-tension and age score; NEWS2 = National Early Warning Score 2; qSOFA = quick Sequential (Sepsis-related) Organ Failure Assessment; ROC = area under the receiver operator curve.

References

    1. World Health Organization . Coronavirus disease (COVID-19) pandemic. WHO, 2020. www.who.int/emergencies/diseases/novel-coronavirus-2019 [Accessed 27 August 2020 ].
    1. Wu C, Chen X, Cai Y, et al. . Risk Factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180:934–43. - PMC - PubMed
    1. Mahida RY, Chotalia M, Alderman J, et al. . Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience. BMJ Open Respiratory Research 2020;7:e000731. - PMC - PubMed
    1. RECOVERY Collaborative Group; Horby P, Lim WS, et al. . Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report. N Engl J Med 2021;384:693–704. - PMC - PubMed
    1. RECOVERY Collaborative Group . Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform study. Lancet 2021;397:1637–45. - PMC - PubMed

Publication types